台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    83.1
  • 漲跌
    ▲2.3
  • 漲幅
    +2.85%
  • 成交量
    221
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 119人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
訊聯 (1784)籌碼相關-玉山-台南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-台南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22082.4000.0083.1004370.00%
2025/01/1600.00081.8082.2004550.00%
2025/01/0800.000.283.5083.50-0.2465-0.04%
2024/12/31079.3000.0079.5004810.00%
2024/12/26182.0000.0080.9015250.19%
2024/12/200.279.1000.0079.100.25440.03%
2024/12/1800.00181.8082.40-1548-0.18%
2024/12/17182.6000.0083.4015820.17%
2024/12/165.185.73982.6082.00-3.9598-0.65%
2024/12/13189.0000.0087.2015870.17%
2024/12/12896.63396.5792.6055800.86%
2024/12/11198.006.198.0797.60-5.1568-0.90%
2024/12/104.193.9200.0093.804.15590.72%
2024/12/091.192.9900.0092.301.15610.19%
2024/12/06095.40398.5095.00-3560-0.53%
2024/12/05499.8000.0099.6045520.72%
2024/12/04298.658102.25100.50-6550-1.09%
2024/12/03496.6000.0095.7045210.77%
2024/12/02397.80396.8096.5005230.00%
2024/11/2900.002.196.9697.00-2.1519-0.40%
2024/11/270.193.2000.0093.100.15270.03%
2024/11/26197.2000.0095.2015380.19%
2024/11/25297.401.197.5597.400.95650.16%
2024/11/21196.50193.3093.3005840.00%
2024/11/20189.601.195.1195.90-0.1565-0.02%
2024/11/150.187.40388.0386.90-2.9629-0.46%
2024/11/14390.80389.1088.4006350.00%
2024/11/08194.00194.7094.1007110.00%
2024/11/0700.000.192.5092.60-0.1716-0.01%
2024/10/24299.0000.0096.2029830.20%
2024/10/21195.0000.0095.1011,1560.09%
2024/10/180.193.5000.0093.100.11,4300.01%
2024/10/160.296.0300.0094.500.21,5540.01%
2024/10/11092.50192.6090.90-11,571-0.06%
2024/10/0900.00197.8096.10-11,585-0.06%
2024/10/0700.00198.3099.40-11,642-0.06%
2024/09/306103.173102.67100.0031,7060.18%
2024/09/2700.00198.9098.90-11,756-0.06%
2024/09/262100.251101.5098.5011,9640.05%
2024/09/2500.00197.6097.60-12,066-0.05%
2024/09/24299.1500.0096.6022,2460.09%
2024/09/202103.252101.75101.0002,2780.00%
2024/09/194105.751105.00102.5032,2880.13%
2024/09/1800.002116.50116.50-22,273-0.09%
2024/09/1100.001102.00102.00-12,425-0.04%
2024/09/101103.5000.00103.0012,4750.04%
2024/09/050.1106.5000.00105.500.12,5660.00%
2024/09/041110.0000.00109.0012,5940.04%
2024/09/031113.5000.00113.5012,6340.04%
2024/09/0200.001116.00116.50-12,691-0.04%
2024/08/301118.503116.50116.50-22,763-0.07%
2024/08/294120.133117.33118.0012,8210.04%
2024/08/283120.831120.50119.0022,8880.07%
2024/08/272120.003121.00122.00-12,958-0.03%
2024/08/262119.752119.75120.5002,9860.00%
2024/08/231115.001115.50115.0003,0100.00%
2024/08/222116.0000.00114.5023,0030.07%
2024/08/213117.173117.67117.0002,9980.00%
2024/08/204116.633.1121.02116.0012,9730.03%
2024/08/190.1112.0000.00111.500.12,9260.00%
2024/08/1400.002111.00112.00-22,956-0.07%
2024/08/134112.255107.40113.50-12,981-0.03%
2024/08/083106.0000.00106.0032,9180.10%
2024/08/071105.501109.00108.5002,9060.00%
2024/08/06198.50299.65103.00-12,890-0.03%
2024/08/051102.501100.9999.5002,8530.00%
2024/08/022112.254112.50110.50-22,818-0.07%
2024/08/013119.001.1118.18117.001.92,8020.07%
2024/07/304117.884117.75116.5002,7790.00%
2024/07/293.1116.734.2118.63113.50-1.12,748-0.04%
2024/07/260.1125.6715125.50126.00-14.92,692-0.55%
2024/07/2328137.0028132.66132.0002,6660.00%
2024/07/2223140.7424.7136.24136.00-1.72,647-0.06%
2024/07/1936.2163.9416.3161.42145.5019.92,5720.77%
2024/07/1811.1158.092161.50161.509.12,3020.40%
2024/07/171147.001147.00147.0002,2110.00%
2024/07/160.1143.0000.00141.500.12,1980.00%
2024/07/151.1142.506143.67143.50-4.92,196-0.22%
2024/07/123140.6723140.50139.00-202,177-0.92%
2024/07/110.1143.5010140.45140.00-9.92,163-0.46%
2024/07/104.1146.1800.00147.504.12,1440.19%
2024/07/091150.501143.50143.5002,1300.00%
2024/07/082140.5000.00146.0022,0830.10%
2024/07/0500.004.3133.14133.00-4.32,039-0.21%
2024/07/0323.1138.263136.00133.0020.12,0081.00%
2024/07/0216137.596136.25140.00101,9350.51%
2024/07/0110.3127.897135.21139.503.31,7290.19%
2024/06/287.4123.6611.3123.00127.00-3.91,623-0.24%
2024/06/262100.505101.78105.00-31,428-0.21%
2024/06/25494.983.295.6095.600.81,3880.06%
2024/06/24594.98594.8294.2001,3710.00%
2024/06/21696.82294.2593.7041,3510.30%
2024/06/20295.35498.0599.40-21,308-0.15%
2024/06/1926.298.5622.295.0194.2041,2790.32%
2024/06/183.395.73497.0396.10-0.71,242-0.06%
2024/06/17188.20294.2591.50-11,195-0.08%
2024/06/14186.003.186.5987.70-2.11,153-0.18%
2024/06/13486.38386.6385.3011,1250.09%
2024/06/12182.903.183.6183.40-2.11,069-0.20%
2024/06/1100.001.185.7682.80-1.11,051-0.11%
2024/06/075.183.78584.5683.000.11,0170.01%
2024/06/06684.48382.5781.2039690.31%
2024/06/05582.563.282.3187.001.89070.20%
2024/06/04386.60282.0580.0018360.12%
2024/06/03583.66485.8885.0017730.13%
2024/05/31478.75482.0882.4006900.00%
2024/05/306.375.111177.1577.30-4.7607-0.77%
2024/05/29273.209.273.7874.00-7.2547-1.32%
2024/05/2700.00167.9068.60-1496-0.20%
2024/05/2400.00167.1067.20-1493-0.20%
2024/05/22269.95170.5069.6014870.20%
2024/05/211.271.4200.0070.001.24790.25%
2024/05/202.870.01172.5071.701.84710.37%
2024/05/170.270.3400.0069.900.24540.05%
2024/05/160.166.4000.0066.200.14220.02%
2024/05/13165.8000.0065.5014150.24%
2024/05/1000.00266.6066.30-2413-0.48%
2024/05/07165.70364.4065.90-2402-0.50%
2024/05/06367.40268.0566.7013960.25%
2024/05/0300.00266.5065.90-2385-0.52%
2024/05/02167.20267.7566.50-1380-0.26%
2024/04/26467.98168.4066.4033550.84%
2024/04/25167.4000.0069.4013090.32%
2024/04/23164.500.264.8064.100.82880.28%
2024/04/221.260.98162.7060.800.22780.07%
2024/04/17162.2000.0061.8012800.36%
2024/04/1600.00161.8061.40-1281-0.36%
2024/04/0800.00166.2066.50-1270-0.37%
2024/04/01066.0000.0063.0002540.00%
2024/03/22163.80164.0064.2002560.00%
2024/03/200.265.81165.0066.00-0.8251-0.32%
2024/03/071.161.9800.0063.001.12270.48%
2024/03/0600.00263.1563.00-2226-0.88%
2024/03/05162.7000.0062.7012260.44%
2024/02/22061.9000.0061.8002220.00%
2024/02/21161.8000.0062.0012200.45%
2024/02/2000.00262.7062.30-2215-0.93%
2024/02/19160.5000.0060.4012020.49%
2024/02/1600.00159.2060.20-1200-0.50%
2024/02/15159.7000.0059.4012010.50%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音